Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
Journal of Hepatology|March 1, 1991
Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver testsJ C Trinchet, D J Hartmann, D Pateron, et al.Alcoholism, Clinical and Experimental Research|April 1, 1992
Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histologyJ C Trinchet, D J Hartmann, D Pateron, et al.Gastroenterologie Clinique Et Biologique|October 8, 1998
[Adult multi-nuclear cell hepatitis. A study in 17 patients]T Tordjmann, S Grimbert, C Genestie, et al.La Revue De Medecine Interne|January 10, 2012
[Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over]M Lahbabi, G N'kontchou, M Aout, et al.La Nouvelle Presse Medicale|April 19, 1980
[Abnormal serum iron carrier in a case of malignant histiocytosis (author's transl)]M Beaugrand, J C Trinchet, J Vaysse, et al.Hepatology (Baltimore, Md.)|November 1, 1996
Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalitiesP Jouët, A Meyrier, F Mal, et al.Gastroenterologie Clinique Et Biologique|January 1, 1989
[Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]J C Trinchet, T Coste, V G Lévy, et al.Gastroenterologie Clinique Et Biologique|January 1, 1993
[Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver]S Grimbert, J C Trinchet, D J Hartmann, et al.Journal of Autoimmunity|March 24, 2000
Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control studyN Ganne-Carrie, A Medini, E Coderc, et al.Cancer|March 1, 1996
Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma HépatocellulaireF Chapel, C Guettier, C Chastang, et al.Pageof 7